Your browser doesn't support javascript.
loading
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.
Harris, Nicole C; Davydova, Natalia; Roufail, Sally; Paquet-Fifield, Sophie; Paavonen, Karri; Karnezis, Tara; Zhang, You-Fang; Sato, Teruhiko; Rothacker, Julie; Nice, Edouard C; Stacker, Steven A; Achen, Marc G.
Afiliação
  • Harris NC; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia; Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.
  • Davydova N; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Roufail S; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Paquet-Fifield S; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Paavonen K; Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.
  • Karnezis T; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Zhang YF; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Sato T; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
  • Rothacker J; Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.
  • Nice EC; Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.
  • Stacker SA; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia; Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3050
  • Achen MG; Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia; Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3050
J Biol Chem ; 288(12): 8176-8186, 2013 Mar 22.
Article em En | MEDLINE | ID: mdl-23404505

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heparina / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Receptor 3 de Fatores de Crescimento do Endotélio Vascular / Fator D de Crescimento do Endotélio Vascular Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heparina / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Receptor 3 de Fatores de Crescimento do Endotélio Vascular / Fator D de Crescimento do Endotélio Vascular Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Austrália